Layer 1
Mur zone | CPD (1980)


E.g., 10/07/2020
E.g., 10/07/2020
What does the Early Access to Medicines Scheme mean for the use of remdesivir to treat COVID-19?
04/06/2020 0 Unplanned learning
Nice has published advice to maximise the safety of immunocompromised children and young people during the pandemic
28/05/2020 0 Unplanned learning
C+D spoke to Regan McCahill, president of the British Pharmaceutical Students’ Association, on how COVID-19 has affected pre-reg students
28/05/2020 3 Podcast
What adverse reactions should be reported for medicines and devices related to COVID-19 treatment?
21/05/2020 0 Unplanned learning
With prescription delivery services stretched during the COVID-19 pandemic, how can pharmacies continue to meet demand while also protecting the...
21/05/2020 3 Unplanned learning
Dr Toni Hazell reveals what advice community pharmacists can give vulnerable patients who are not on the shielded list, such as those aged over 70
14/05/2020 0 Podcast
When should personal protective equipment be worn in the pharmacy?
14/05/2020 0 Unplanned learning
What is the latest advice for the use of chloroquine and hydroxychloroquine in the prevention or treatment of COVID-19?
06/05/2020 0 Unplanned learning
Nice has published a rapid guideline for the care of patients with cystic fibrosis (CF) during the COVID-19 pandemic, including those with suspected...
06/05/2020 0 Unplanned learning